EDMONTON, AB, May 30, 2024 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that it has restated and refiled its January 31, 2023 annual audited financial statements and its interim unaudited financial statements for the three months ended April 30, 2023, six months ended July 31, 2023 and nine months ended October 31, 2023 each with relevant comparative periods, and the related management's discussion and analysis for those periods. The restated financial statements and related MD&A have been filed on SEDAR+ (www.sedarplus.ca) which are available for viewing and download under the Company's SEDAR+ profile and at the Company's website.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
